Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploring the association between cannabis use and depression.

Louisa Degenhardt1, Wayne Hall, Michael Lynskey

  • 1National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. l.Degenhardt@unsw.edu.au

Addiction (Abingdon, England)
|November 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data Resource Profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia.

International journal of epidemiology·2020
Same author

Substantial Decline in Use of HIV Preexposure Prophylaxis Following Introduction of COVID-19 Physical Distancing Restrictions in Australia: Results From a Prospective Observational Study of Gay and Bisexual Men.

Journal of acquired immune deficiency syndromes (1999)·2020
Same author

Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Pain·2020
Same author

All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysis.

Pain medicine (Malden, Mass.)·2020
Same author

General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews.

Pain·2020
Same author

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia.

Journal of hepatology·2020

Heavy cannabis use is modestly associated with depression. Longitudinal studies suggest it may increase depressive symptoms, but common factors could also explain the link.

Area of Science:

  • Psychiatry
  • Epidemiology
  • Addiction Medicine

Background:

  • The relationship between cannabis use and depression is complex and requires thorough investigation.
  • Understanding this association is crucial for public health and clinical practice.

Purpose of the Study:

  • To systematically review and synthesize evidence on the association between cannabis use and depression.
  • To evaluate potential explanations for the observed association, including causality and confounding factors.

Main Methods:

  • Comprehensive literature search of Medline, Psychinfo, and EMBASE databases.
  • Inclusion of research studies examining terms related to cannabis (cannabis, marijuana, cannabinoid) and depression (depression, mood, dysthymia).
  • Exclusion of case reports to focus on robust research designs.

Related Experiment Videos

Main Results:

  • A modest association was found between heavy or problematic cannabis use and depression in cohort and cross-sectional studies.
  • Early-onset, regular cannabis use showed a modest association with later depression, even after controlling for confounders.
  • Limited evidence supported the self-medication hypothesis; depression did not consistently predict later cannabis use.

Conclusions:

  • Heavy cannabis use is associated with depression, with longitudinal data suggesting a potential increase in depressive symptoms for some users.
  • The possibility of common social, familial, or contextual factors influencing both cannabis use and depression cannot be ruled out.
  • Further longitudinal and twin studies are needed to elucidate the causal relationship and the extent of cannabis's contribution to population depression prevalence.